Eckert & Ziegler Strahlen- und Medizintechnik AG (0NZY.L)

142,16 -0,37 (-0,26%) Alla chiusura: 4:37PM BST

Eckert & Ziegler Strahlen- und Medizintechnik AG

Robert-Rössle-Strasse 10
Berlin 13125
Germany
49 30 94 10 84 0
http://www.ezag.com

Settore/i: 
Settore: 
Impiegati a tempo pieno: 825

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Dr. Andreas Eckert Ph.D.	Chairman of Exec. Board & CEO	476,52k	N/D	1960
Dr. Harald Hasselmann	Head of Radiation Therapy Segment & Member of the Exec. Board	240,94k	N/D	1967
Dr. Lutz Helmke	Member of Exec. Board	252,03k	N/D	1961
Dr. Gunnar Mann	Head of Intragroup Services	N/D	N/D	1967
Mr. Franklin B. Yeager	Pres of Eckert & Ziegler Isotope Products Inc.	N/D	N/D	N/D
Mr. Joseph Hathcock	VP of Eckert & Ziegler Isotope Products Inc	N/D	N/D	N/D
Ivan Simmer	Managing Director of Eckert & Ziegler Cesio s.r.o.	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2019 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in EUR.

Descrizione

Eckert & Ziegler Strahlen- und Medizintechnik AG, through its subsidiaries, provides isotope technology components for medical, scientific, and industrial use worldwide. It operates through three segments: Radiation Therapy, Radiopharma, and Isotope Products. The Radiation Therapy segment develops, manufactures, markets, and sells radioactive products for cancer therapy. This segment offers small radioactive implants for the treatment of prostate cancer seeds; and tumor radiation devices and eye applicators. This segment's products and equipment are used by oncologists, radiotherapists, urologists, ophthalmologists, and medical physicists. The Radiopharma segment operates in the field of molecular imaging and nuclear medicine; and supplies various radiopharmaceuticals, radiochemicals, and related equipment for the synthesis and radiochromatography of PET/SPECT tracers and other radioisotopes. This segment provides products in the categories of radiosynthesis technology, radiochromatography, and radionuclides. The Isotope Products segment offers sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration, and environmental monitoring sources and solutions; and bulk radioisotopes for pharmaceutical, therapeutic, and industrial product manufacturers. It also provides custom and one-off design and manufacturing services. In addition, the company offers services for collection, recycling, and disposal of sealed radioactive sources and low activity isotope related waste from hospitals, research institutes, and industries. Eckert & Ziegler Strahlen- und Medizintechnik AG was founded in 1992 and is headquartered in Berlin, Germany.

Governance aziendale

L'ISS Governance QualityScore di Eckert & Ziegler Strahlen- und Medizintechnik AG al 1 dicembre 2020 è 10. I criteri di valutazione fondamentali sono revisione: 5; Consiglio di Amministrazione: 10; diritti degli azionisti: 7; retribuzione: 7.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.